Search Results1-20 of  24

  • 1 / 2
  • MIYAMOTO Norimasa ID: 9000011233445

    Laboratory of Seeds Finding Technology, Eisai Co., Ltd. (2001 from CiNii)

    Articles in CiNii:1

    • ADAM22 deficient mice exhibit severe ataxia (2001)
  • MIYAMOTO Norimasa ID: 9000345266343

    Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)|Eisai Co., Ltd. (2016 from CiNii)

    Articles in CiNii:1

    • An attempt to establish the evaluation system for drug-induced epilepsy by applying microelectrode array recording to human iPS cell-derived neurons -activity report from CSAHi CNS/PNS group (2016)
  • MIYAMOTO Norimasa ID: 9000345266865

    Eisai Co., Ltd.|Japan iPS Cardiac Safety Assessment (JiCSA) (2016 from CiNii)

    Articles in CiNii:1

    • Development of torsadogenic risk classification method using human induced pluripotent stem cell-derived cardiomyocytes and multi-electrode array system (2016)
  • MIYAMOTO Norimasa ID: 9000345266939

    Consortium for Safety Assessment using Human iPS Cells|Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-Clinical Evaluation Expert Committee|Japan iPS Cardiac Safety Assessment|Eisai Co., Ltd. (2016 from CiNii)

    Articles in CiNii:1

    • Assessment of arrhythmogenic assay in human induced pluripotent stem cell-derived cardiomyocytes (Cor.4U) using a multielectrode array system – Collaboration between CSAHi and JiCSA (2016)
  • MIYAMOTO Norimasa ID: 9000345267066

    Japan iPS Cardiac Safety Assessment (JiCSA)|Eisai Co., Ltd. (2016 from CiNii)

    Articles in CiNii:1

    • Pharmacological characterization of human iPS cell-derived cardiomyocytes for assessing drug-induced, reverse use-dependent prolongation of field potential duration and pro-arrhythmic potential (2016)
  • MIYAMOTO Norimasa ID: 9000347139493

    Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-Clinical Evaluation Expert Committee|Consortium for Safety Assessment using Human iPS Cells|Eisai Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Assessment of arrhythmogenic potential in human induced pluripotent stem cell-derived cardiomyocytes using a multielectrode array (MED64) (2014)
  • MIYAMOTO Norimasa ID: 9000347140025

    Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-Clinical Evaluation Expert Committee|Consortium for Safety Assessment using Human iPS Cells|Eisai Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Basic research for property of human iPS cells-derived neurons (Consortium for safety assessment using human iPS cells) (2014)
  • MIYAMOTO Norimasa ID: 9000347140030

    Eisai Co., Ltd.|Consortium for Safety Assessment using Human iPS Cells (2014 from CiNii)

    Articles in CiNii:1

    • Cell property analysis using a DNA microarray of human iPS-derived hepatocytes: Comparative analysis between cell types (2014)
  • MIYAMOTO Norimasa ID: 9000347193303

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)|Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Eisai Co., Ltd. (2015 from CiNii)

    Articles in CiNii:1

    • Global gene expression profiling of human induced pluripotent stem cell-derived cardiomyocytes: Consortium for safety assessment using human iPS cells study (2015)
  • MIYAMOTO Norimasa ID: 9000347193523

    Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-Clinical Evaluation Expert Committee|Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Eisai Co., Ltd. (2015 from CiNii)

    Articles in CiNii:1

    • CSAHi study: Prediction of drug-induced proarrhythmia in human iPS cell-derived cardiomyocytes with multi-electrode arrays (MED64) (2015)
  • MIYAMOTO Norimasa ID: 9000347193571

    Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)|Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Eisai Co., Ltd. (2015 from CiNii)

    Articles in CiNii:1

    • Fundamental study on glutamic acid response pathways of human iPSC-derived neurons - CSAHi Neuron and Cell Characterization (2015)
  • MIYAMOTO Norimasa ID: 9000347193632

    Eisai Co., Ltd.|Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)|Consortium for Safety Assessment using Human iPS Cells (CSAHi) (2015 from CiNii)

    Articles in CiNii:1

    • Investigation for quality marker genes in human iPS-derived hepatocytes (iPS-Hep) for application to toxicity studies (2015)
  • MIYAMOTO Norimasa ID: 9000347193866

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)|Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Eisai Co., Ltd. (2015 from CiNii)

    Articles in CiNii:1

    • Activity of the consortium for safety assesment using human iPS cells, global trend, and global cooperation (2015)
  • MIYAMOTO Norimasa ID: 9000386308156

    Three-Dimensional Culture Team, Consortium for Safety Assessment Using Human iPS Cells (CSAHi-3D)|Eisai Co., Ltd. (2017 from CiNii)

    Articles in CiNii:1

    • CSAHi-3D: A collaborative study to develop a novel cell culture system for hepatotoxicity assessment (2017)
  • MIYAMOTO Norimasa ID: 9000386308914

    Eisai Co., Ltd.|Consortium for Safety Assessment using Human iPS Cells (CSAHi)|iPS Non-clinical Experiments for Nervous System (iNCENS) (2017 from CiNii)

    Articles in CiNii:1

    • Trial for data analysis of drug responses in primary rodent neurons and human induced pluripotent stem cell‐derived neurons using MEA and deep learning (2017)
  • MIYAMOTO Norimasa ID: 9000386308920

    Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Eisai Co., Ltd. (2017 from CiNii)

    Articles in CiNii:1

    • An attempt to establish the evaluation system for drug-induced epilepsy by applying microelectrode array recording to human iPS cell-derived neurons -activity report from CSAHi CNS/PNS group (2017)
  • MIYAMOTO Norimasa ID: 9000397801583

    Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Eisai Co., Ltd. (2018 from CiNii)

    Articles in CiNii:1

    • An attempt to establish the evaluation system for drug-induced epilepsy by applying microelectrode array recording to human iPS cell-derived neurons -activity report from CSAHi Neuro group (2018)
  • MIYAMOTO Norimasa ID: 9000403274771

    Consortium for Safety Assessment using Human iPS Cells (CSAHi)|Eisai Co., Ltd. (2019 from CiNii)

    Articles in CiNii:1

    • An attempt to establish the evaluation system for drug-induced epilepsy by applying microelectrode array recording to human iPS cell-derived neurons -activity report from CSAHi Neuro group (2019)
  • MIYAMOTO Norimasa ID: 9000403274778

    Global Cardiovascular Assessment, Eisai Co., Ltd.|Team Neuron, Consortium for Safety Assessment using Human iPS Cells (CSAHi) (2019 from CiNii)

    Articles in CiNii:1

    • Trial of multi-metric parameter analysis for drug-induced seizure risk assessment using cultured neurons and microelectrode array system (2019)
  • Miyamoto Norimasa ID: 9000243880147

    Biopharmaceutical Assessments Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., Japan (2014 from CiNii)

    Articles in CiNii:1

    • Assessment of Testing Methods for Drug-Induced Repolarization Delay and Arrhythmias in an iPS Cell–Derived Cardiomyocyte Sheet: Multi-site Validation Study (2014)
  • 1 / 2
Page Top